A Randomized Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 06 Jan 2012 New trial record
- 04 Jan 2012 Biomarkers information updated